Skip to content

Efficacy of remimazolam combined with etomidate or propofol for gastroenteroscopy: a single-center, randomized controlled clinical trial

Efficacy of remimazolam combined with etomidate or propofol for gastroenteroscopy: a single-center, randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085904
Enrollment
Unknown
Registered
2024-06-20
Start date
2024-03-23
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia without intubation

Interventions

R-E Group:Sedation/anesthesia was induced using remimazolam (0.15 mg/kg) in combination with etomidate (0.1 mg/kg). Additional remimazolam (2.5mg each) was added intermittently during maintenance.
R-P Group:Sedation/anesthesia was induced using remimazolam (0.15 mg/kg) in combination with propofol (0.75 mg/kg). Additional remimazolam (2.5mg each) was added intermittently during maintenance.

Sponsors

Qingdao Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) age >18 years, elective gastroenteroscopy under procedural sedation; (2) ASA I-III.

Exclusion criteria

Exclusion criteria: (1) Refusal to sign the informed consent form;(2) Severe respiratory depression;(3) Acute or severe bronchial asthma;(4) Known or suspected gastrointestinal obstruction;(5) Known hypersensitivity to the drugs and ingredients used in this study;(6) Severe hepatic, renal, or adrenal insufficiency;(7) Long-term use of opioids;(8) Long-term use of benzodiazepines;(9) Anticipated difficult airway;(10) Adrenocortical insufficiency.

Design outcomes

Primary

MeasureTime frame
respiratory depression;

Secondary

MeasureTime frame
hypoxemia;airway intervention;Sedation/anesthesia success rate;

Countries

China

Contacts

Public ContactShoushi Wang

Qingdao Central Hospital

wangshoushi1226@126.com+86 185 6185 6159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026